- Advertising
- Asia
- Bangladesh
- Biological Inventions
- BRAND VALUATION
- China
- Comparative Advertisement
- Copyright
- Copyright Infringement
- Copyright Litigation
- Counterfeiting
- Covid
- Design
- Digital Marketing Rights
- DRM
- Geographical Indication
- India
- Indian Patents Act
- Indonesia
- Intellectual Property
- Interim Injunction
- IP Commercialization
- IP Licensing
- IP Litigation
- IP Practice in India
- IPAB
- IPAB Decisions
- Japan
- Legal Issues
- Licensing
- Malaysia
- Myanmar
- NCLT
- NEPAL
- Net Neutrality
- News & Updates
- Office
- Patent Commercialisation
- Patent Cooperation Treaty
- patent infringement
- Patent Licensing
- Patent Litigation
- Patent Opposition
- Patent Prosecution
- Patent Rule Amendment
- Patent Term Extension
- Patents
- pharma
- Philippines
- Punitive Damages
- Section 3(D)
- section 64
- Singapore
- South-east Asia
- Technology
- Technology Transfer
- Thailand
- Trademark
- Trademark Litigation
- Uncategorized
- USPTO
- Vietnam
- WIPO
Sunovion Pharmaceuticals and Bial Portela Files Patent Infringement Suit against A Host of Indian Drug Makers
Recently, The Bial – Portela & CA (“Bial”), a Portugal-based pharmaceutical company, and Sunovion Pharmaceuticals (“Sunvion”), a US-based pharmaceutical company have instituted suit of patent infringement against eight drug makers in the District Court of Delaware. The eight defendants are: Torrent Pharmaceuticals and Torrent Pharma Inc., Alkem Laboratories and S&B Pharma, Inc., Lupin Limited and … Continue reading Sunovion Pharmaceuticals and Bial Portela Files Patent Infringement Suit against A Host of Indian Drug Makers
Read more »Daedalus Blue Sues Microsoft For Patent Infringement
Recently Daedalus Blue LLC has sued tech giant Microsoft over patent infringement. The suit has been filed in Western District of Texas (case no 6:20-cv-01152, Daedalus Blue LLC v. Microsoft Corporation). Daedalus Blue claims that Microsoft’s Azure cloud computing product infringes its patents which essentially deals with cloud and cloud-based technology. Daedalus Blue is seeking … Continue reading Daedalus Blue Sues Microsoft For Patent Infringement
Read more »Tearing Down A Product to Look for Patent Infringement
In today’s world where most companies depend on other manufacturers to supply them with the necessary components to build a desired end product, it becomes strikingly important for a patent asserting body to understand the infringing parties and their role and significance in carrying out the infringement by the accused product. Product teardown reporting is … Continue reading Tearing Down A Product to Look for Patent Infringement
Read more »Khurana & Khurana Opens Jalandhar (Punjab) Office
May 11, 2019 - 11:47 am
Categories:
Copyright
Copyright Infringement
Copyright Litigation
Intellectual Property
IP Commercialization
IP Licensing
IP Litigation
Licensing
Office
patent infringement
Patent Licensing
Patent Litigation
Patent Prosecution
Patents
Trademark
Trademark Litigation
0 Comments
Upon successful practicing in the area of Intellectual Property (IP) and Commercial Litigation over the decade, Khurana & Khurana, Advocates and IP Attorneys together with its IP Asset Management Practice, IIPRD, feels immense pleasure to announce the recent opening of its 8th branch in Jalandhar. With years of helping corporates identify, create, protect, promote and … Continue reading Khurana & Khurana Opens Jalandhar (Punjab) Office
Read more »BLACKBERRY SUES NOKIA FOR PATENT INFRINGEMENT: AN OVERVIEW
February 27, 2017 - 10:28 am
Categories:
India
News & Updates
patent infringement
Uncategorized
0 Comments
The once powerful mobile phone companies BlackBerry and Nokia are in the headlines again, not for their new technological developments but because of their legal battle. The Valentine’s Day card for Nokia was in the form of complaint entailing 11 items that Blackberry did not like about it. The complaint listed out the 11 patents … Continue reading BLACKBERRY SUES NOKIA FOR PATENT INFRINGEMENT: AN OVERVIEW
Read more »Teva held responsible for Induced Infringement of Eli Lilly’s Blockbuster drug ALITMA
February 24, 2017 - 1:44 pm
Categories:
IP Litigation
News & Updates
patent infringement
Patents
0 Comments
In Teva Parenteral Medicines, Inc.; APP Pharmaceuticals LLC; Pliva Hrvatska D.O.O.; Teva Pharmaceuticals USA, Inc.; and Barr Laboratories, Inc. (hereinafter referred to be as Defendants/Appellants/Teva) Vs. Eli Lilly & Co. (hereinafter referred to as Plaintiff/Appelle/Eli Lilly) decided by United States Court of Appeals for the Federal Circuit (CAFC) on January 12, 2017, Plaintiff had filed … Continue reading Teva held responsible for Induced Infringement of Eli Lilly’s Blockbuster drug ALITMA
Read more »Hetero’s Subsidiaries not infringing Roxane’s patent on PhosLo
In Roxane Laboratories, Inc. (hereinafter referred to be as “Roxane”) v. Camber Pharmaceuticals Inc., et al. (hereinafter referred to as “Camber”) decided by United States Court of Appeals for the Federal Circuit on November 17, 2016, Roxane had appealed against decision of district court in an infringement suit against Camber and Invagen Pharmaceuticals Inc (collectively … Continue reading Hetero’s Subsidiaries not infringing Roxane’s patent on PhosLo
Read more »Does Focusing on Single Embodiment Limits the Patent Specification?
August 31, 2016 - 6:12 am
Categories:
News & Updates
patent infringement
Patent Litigation
Patents
0 Comments
This issue was handled by the United States Court of Appeals for the Federal Circuit in the SCRIPTPRO LLC, SCRIPTPRO USA, INC., Plaintiffs-Appellants v. INNOVATION ASSOCIATES, INC., Defendant-Appellee decided on August 15, 2016. This was an appeal from the United States District Court for the District of Kansas in No. 2:06-cv-02468-CM, Judge Carlos Murguia. United … Continue reading Does Focusing on Single Embodiment Limits the Patent Specification?
Read more »Only Common Sense Not Sufficient to Prove Obviousness Over Prior Art
August 31, 2016 - 5:56 am
Categories:
News & Updates
patent infringement
Patent Litigation
Patents
0 Comments
Can the grant of patent be rejected on the obviousness criteria based only on common sense? This issue has been handled by United States Court of Appeals for the Federal Circuit in the case of ARENDI S.A.R.L., Appellant v. APPLE INC., GOOGLE INC., MOTOROLA MOBILITY LLC, Appellees, decided on August 10, 2016. On December 2, … Continue reading Only Common Sense Not Sufficient to Prove Obviousness Over Prior Art
Read more »CO2 Solutions Wins Patent Challenge Against Akermin in Denmark
CO2 Solutions Inc, a leader in the field of enzyme-enabled carbon capture technology, has successfully defended its broad intellectual property (IP) rights to its enzyme-enabled carbon capture technology in a case brought against it by U.S.-based Akermin Inc. in Denmark. Based in Quebec City, CO2 Solutions Inc. is an innovator in the field of enzyme-enabled … Continue reading CO2 Solutions Wins Patent Challenge Against Akermin in Denmark
Read more »